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Figure S1. Key steps in the synthesis of the macrocyclic polyamides 2 and 3. 
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Figure S2. Internal standard used for HPLC experiments. 
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Figure S3. HPLC traces of the compounds 1-4. 
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Figure S4. Calibration of the analytical HPLC peaks over the range of 0-100 μM 1. Linear regression was performed using 
the module implemented in OriginPro 8.  
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Figure S5. Reproducibility of injection (polyamide 1, 120 nmol / animal). A: IP-injection; B: SC-injection. Blood collected 
1.5 h after the injections, with four replicates (R1 - 4) for each injection route. 
 
Table S1. Reproducibility of injection (polyamide 1, 120 nmol / animal). A: IP-injection; B: SC-injection. Blood collected 
1.5 h after the injections, with four replicates (R1 - 4) for each injection route. 
 IP (Area) SC (Area) 
R1 188326 110749 
R2 190669 122785 
R3 162508 96690 
R4 161090 93466 
Average 175648 105923 
STD 16131 13516 
% Error 9.2 12.8 
 
 
